PORTLAND, GA, UNITED STATES, November 5, 2024 /EINPresswire / -- The global Implantable Insulin Pump Market was pegged at $2.67 billion in 2020, and is estimated to reach $6.44 billion by 2030, ...

Insulin pump therapy, also known as continuous subcutaneous ... of safety information but is insufficiently utilized due to the current configuration of the system; the comparable database in ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

The S&P 500 added 0.4% on Friday, Nov. 8, posting its highest-ever close to end a momentous week that included an election ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery - Observed weight loss was 17% at 28 days, a 25% ...

Wells Fargo analyst Larry Biegelsen assigned a Buy rating to Insulet (PODD – Research Report) today and set a price target of $290.00.

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

Māori and Pacific people with type 1 diabetes are less likely to be current insulin pump users. This means there is a clear risk of workforce shortages causing those who would benefit most from ...

The company has a debt-to-equity ratio of 1.29, a current ratio of 2.90 and a quick ratio ... The company's flagship product ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.